We’re excited to announce our Malta expansion is complete!
We will be returning to our 658 Malta location beginning Monday, August 27, 2018.
- Posted on: Jul 24 2018
We will be returning to our 658 Malta location beginning Monday, August 27, 2018.
Due to a labeling error, Fresenius Kabi USA is voluntarily recalling lot 6400048 of Midazolam Injection, USP, 2 mg/2 mL. Source: AAO
A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent, is safe for treatment of retinal diseases. Source: AAO
This cross-sectional study describes the phenotypical characteristics of AMD patients carrying a rare variant in the complement factor H gene. Source: AAO
This randomized sham-controlled trial evaluated the safety and efficacy of corneal crosslinking for patients who developed corneal ectasia after laser refractive surgery. Source: AAO
The FDA has approved latanoprostene bunod (Vyzulta), a nitric oxide-donating prostaglandin analog, for reducing IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »